| Literature DB >> 36061065 |
Jiawei Shen1, Youzhong An2, Baoguo Jiang1,3,4, Peixun Zhang1,3,4.
Abstract
Introduction: Postoperative delirium is a common complication of patients undergoing hip fracture surgery or arthroplasty and is related to decreased survival time and physical function. In this study, we aim to build and validate a prediction score of postoperative delirium in geriatric patients undergoing hip fracture surgery or hip arthroplasty.Entities:
Keywords: arthroplasty; complications; delirium; hip fracture; prognosis
Year: 2022 PMID: 36061065 PMCID: PMC9437918 DOI: 10.3389/fsurg.2022.919886
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Number of included patients in different inclusion periods and the number of postoperative delirium cases.
Baseline characteristics of patients in the derivation cohort who did or did not develop postoperative delirium.
| Characteristic | Total | Delirium | |
|---|---|---|---|
| No | Yes | ||
| −85.67% | −14.33% | ||
| Age, years | |||
| 60–69 | 210(16.01) | 204(18.15) | 6(3.19) |
| 70–79 | 375(28.58) | 330(29.36) | 40(21.28) |
| 80–89 | 605(46.11) | 502(44.66) | 108(57.45) |
| ≥90 | 122(9.30) | 88(7.83) | 34(18.09) |
| Sex | |||
| Female (%) | 896(68.29) | 766(68.15) | 130(69.15) |
| Male (%) | 416(31.71) | 358(31.85) | 58(30.85) |
| BMI, kg/m2 | |||
| <20 | 430(32.77) | 376 (33.45) | 54(28.72) |
| 20–25 | 591(45.05) | 502(44.66) | 89(47.34) |
| 25–30 | 246(18.75) | 207(18.42) | 39(20.74) |
| >30 | 45(3.43) | 39(3.47) | 6(3.10) |
| CCI score | 5(3–7) | 5(3–6) | 7(4–9) |
| History of major fractures | 354(26.98) | 299(26.60) | 55(29.25) |
| Preoperative dementia | 35(2.67) | 7(0.53) | 28(2.13) |
| Preoperative delirium | 102(7.77) | 49(4.36) | 53(28.19) |
| Hearing loss | 104(7.93) | 90(8.01) | 14(7.45) |
| Psychiatric disease | 46(3.51) | 39(3.47) | 7(3.72) |
| Coronary heart disease | 340(25.91) | 293(26.07) | 47(25.00) |
| Chronic heart failure | 26(1.98) | 20(1.78) | 6(3.19) |
| Atrial fibrillation | 106(8.08) | 67(5.96) | 39(20.74) |
| Hypertension | 793(60.44) | 694(61.74) | 99(52.66) |
| Peripheral vascular disease | 60(4.57) | 55(4.89) | 5(2.66) |
| Diabetes | 365(27.82) | 299(26.60) | 66(35.11) |
| Chronic kidney disease | 131(9.98) | 97(8.63) | 34(18.09) |
| Acute kidney injury | 14(1.10) | 8(0.71) | 6(3.19) |
| Presurgery dialysis | 12(0.92) | 9(0.80) | 3(1.60) |
| Hepatic failure | 6(0.46) | 5(0.44) | 1(0.53) |
| Malignancy | 206(15.71) | 167(14.86) | 39(20.74) |
| Alcohol abuse | 33(2.52) | 27(2.43) | 6(3.17) |
| Active Smoker | 93(7.09) | 75(6.67) | 18(9.57) |
| CVA with the Rankin scale | |||
| 4–5 | 15(1.14) | 4(0.36) | 11(5.85) |
| 2–3 | 100(7.62) | 41(3.65) | 59(31.38) |
| 0–1 | 166(12.65) | 91(8.10) | 75(39.89) |
| COPD | 46(3.506) | 43(3.825) | 3(1.60) |
| Symptomatic PE | 7(0.51) | 5(0.44) | 2(1.06) |
| Preoperative pneumonia | 228(17.38) | 198(17.62) | 30(15.96) |
| ASA score | 2(1–2) | 2(1–2) | 2(2–3) |
| Type of fracture | |||
| Femoral neck | 722(55.03) | 661(58.81) | 61(32.45) |
| Intertrochanteric | 516(39.33) | 396(35.23) | 120(63.83) |
| Subtrochanteric | 28(2.13) | 21(1.87) | 7(3.72) |
| Periprosthetic | 20(1.53) | 16(1.42) | 4(2.13) |
| Multiple hip fractures | 26(1.98) | 19(1.67) | 7(3.72) |
| Type of surgery | |||
| Intramedullary nail | 614(46.81) | 562(50.00) | 52(27.66) |
| Cancellous screw | 73(5.56) | 59(5.25) | 14(7.45) |
| Hemiarthroplasty | 470(35.82) | 421(37.41) | 49(26.06) |
| Total hip arthroplasty | 148(11.28) | 135(12.01) | 13(6.91) |
| Revision of arthroplasty | 7(0.53) | 6(0.53) | 1(0.52) |
| Surgical delay | |||
| <24 h | 85(6.48) | 67(5.96) | 8(4.26) |
| 24–48 h | 1055(80.4) | 927(82.47) | 138(73.40) |
| >48 h | 172(13.1) | 130 (11.57) | 42(22.34) |
| Duration of surgery (h) | 3.11 ± 0.91 | 3.11 ± 0.5 | 3.49 ± 0.88 |
| General anesthesia | 161(12.27) | 139(12.37) | 22(11.7) |
| High-risk medications in surgery | |||
| Benzodiazepines | 103(7.85) | 35(3.11) | 68(36.17) |
| Opioids | 332(25.30) | 289(25.71) | 43(22.87) |
| NSAIDs | 258(19.66) | 222(19.75) | 36(19.14) |
| Glucose level for patients with diabetes (mmol/L) | 8.77 ± 1.64 | 7.96 ± 2.55 | 8.43 ± 1.38 |
| Sodium (mmol/L) | 136.09 ± 16.21 | 135.53 ± 17.38 | 139.47 ± 3.67 |
| BUN (mg/dL) | 6.69(5.16–8.8) | 6.41(5.00–8.41) | 7.81(6.29–10.88) |
| Creatine (mmol/L) | 69(56–94) | 62(59–107) | 70(55–95) |
| Albumin (mmol/L) | 35.62 ± 4.89 | 35.82 ± 5.02 | 34.4 ± 4.85 |
| White blood cell count (×109/L) | 8.06 ± 2.73 | 8.00 ± 2.53 | 8.39 ± 3.66 |
| Hemoglobin (g/L) | 119(101–131) | 110(92–130) | 97(90–113) |
Data are given as a number (%), mean + standard deviation, or median (interquartile range).
ADL, activities of daily living; BMI, body mass index; BUN, blood urea nitrogen; CCI, Carlson comorbidity index; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease; NSAIDs, nonsteroidal anti-inflammatory drugs; PE, pulmonary embolism.
Multivariate regression of postoperative delirium.
| Variable | OR | 95% CI |
|
|---|---|---|---|
| Preoperative delirium | 4.21 | 3.25–9.14 | <0.001 |
| CVA with the modified Rankin scale | |||
| 4–5 | 3.17 | 1.16–5.06 | <0.001 |
| 2–3 | 2.25 | 1.26–4.29 | |
| 0–1 | – | ||
| Diabetes with random glucose level | 0.023 | ||
| >13 mmol/L | 2.43 | 1.32–2.99 | |
| 8–13 mmol/L | 1.36 | 1.15–1.67 | |
| <8 mmol/L | – | ||
| CCI score | 0.008 | ||
| ≥9 | 2.32 | 1.69–4.83 | |
| 6–8 | 1.29 | 1.03–2.52 | |
| ≤5 | – | ||
| Age (years) | |||
| ≥80 | 1.87 | 1.25–2.50 | 0.021 |
| 70–79 | 1.11 | 1.07–2.19 | |
| 60–69 | – | ||
| Application of Benzodiazepines in surgery | 1.44 | 1.24–3.17 | 0.036 |
| Surgical delay ≥2 days | 1.15 | 1.13–1.28 | 0.012 |
| Creatine ≥90 μmol/L | 1.09 | 1.02–1.13 | 0.034 |
| Active smoker | 1.05 | 1.04–1.94 | 0.042 |
| General anesthesia | 1.32 | 0.32–1.63 | 0.751 |
| BUN >8.5 mmol/L | 1.15 | 0.62–1.77 | 0.812 |
| Albumin ≤30 g/L | 1.08 | 0.86–1.26 | 0.623 |
Without CVA.
Without diabetes.
ADL, activities of daily living; BUN, blood urea nitrogen; CCI, Carlson comorbidity index; CI, confidence interval; CVA, cerebrovascular accident; OR, odds ratio.
Prediction score of postoperative delirium for patients after hip fracture surgery or hip arthroplasty.
| Variable | Score |
|---|---|
| Preoperative delirium | 4 |
| CVA with the modified Rankin scale | |
| ≥4 | 3 |
| 2–3 | 2 |
| 0–1 | 0 |
| Diabetes with random glucose level | |
| >13 mmol/L | 2 |
| 8–13 mmol/L | 1 |
| <8 mmol/L | 0 |
| CCI score | |
| ≥9 | 2 |
| 6–8 | 1 |
| ≤5 | 0 |
| Age (years) | 2 |
| ≥80 | 1 |
| 70–79 | 0 |
| 60–69 | |
| Application of benzodiazepines in surgery | 1 |
| Surgical delay ≥2 days | 1 |
| Creatine ≥90 μmol/L | 1 |
| Active smoker | 1 |
aWithout CVA.
bWithout diabetes.
ADL, activities of daily living; CCI, Carlson comorbidity index; CVA, cerebrovascular accident.
Figure 2Comparison of the performance of the predicting models from the present study and two previous studies. AUC, area under the curve.
Baseline characteristics of patients in the validation cohort who did or did not develop postoperative delirium.
| Characteristic | Total | Delirium | |
|---|---|---|---|
| No | Yes | ||
| −81.87% | −18.13% | ||
| Age, years | |||
| 60–69 | 51(14.45) | 49(16.96) | 2(3.13) |
| 70–79 | 78(22.10) | 66(22.84) | 10(15.63) |
| 80–89 | 165(46.74) | 135(46.71) | 30(46.88) |
| ≥90 | 59(16.71) | 39(13.49) | 22(34.38) |
| Sex | |||
| Female (%) | 235(66.57) | 196(67.82) | 39(60.94) |
| Male (%) | 118(33.43) | 93(32.18) | 25(39.06) |
| BMI, kg/m2 | |||
| <20 | 116(32.86) | 96(33.21) | 20(31.25) |
| 20–25 | 160(45.33) | 131(45.33) | 29(45.31) |
| 25–30 | 64(18.13) | 51(17.65) | 13(20.31) |
| >30 | 13(3.68) | 11(3.81) | 2(3.13) |
| CCI score | 6(3–6) | 5(3–6) | 5(3–9) |
| History of major fractures | 89(25.21) | 71(24.57) | 18(28.13) |
| Preoperative dementia | 29(8.22) | 23(7.96) | 6(9.38) |
| Preoperative delirium | 16(4.53) | 9(3.11) | 7(10.94) |
| Hearing loss | 21(5.95) | 19(5.38) | 2(3.13) |
| Psychiatric disease | 13(3.68) | 11(3.81) | 2(3.13) |
| Coronary heart disease | 82(23.23) | 67(23.18) | 15(23.44) |
| Chronic heart failure | 6(1.70) | 5(1.73) | 1(1.56) |
| Atrial fibrillation | 27(7.65) | 18(6.23) | 9(14.06) |
| Hypertension | 207(58.64) | 173(59.86) | 34(53.13) |
| Peripheral vascular disease | 16(4.53) | 16(5.54) | 0(0) |
| Diabetes | 99(28.05) | 70(24.22) | 29(45.31) |
| Chronic kidney disease | 34(9.63) | 20(6.92) | 14(21.88) |
| Acute kidney injury | 8(2.27) | 5(1.73) | 3(4.69) |
| Presurgery dialysis | 6(1.70) | 4(1.38) | 2(3.13) |
| Hepatic failure | 5(1.42) | 3(1.04) | 2(3.13) |
| Malignancy | 51(14.45) | 39(13.49) | 12(18.75) |
| Alcohol abuse | 9(2.55) | 7(2.42) | 2(3.13) |
| Active smoker | 26(7.37) | 22(7.61) | 4(6.25) |
| CVA with the Rankin scale | |||
| 4–5 | 9(2.55) | 5(1.73) | 4(6.25) |
| 2–3 | 23(6.52) | 7(2.42) | 16(25.00) |
| 0–1 | 11(3.12) | 5(1.73) | 6(9.38) |
| COPD | 13(3.68) | 6(2.08) | 7(10.94) |
| Symptomatic PE | 1(0.28) | 1(3.45) | 0(0) |
| ASA score | 2(1–2) | 2(1–2) | 2(1–3) |
| Preoperative pneumonia | 57(16.15) | 34(11.76) | 70(37.23) |
| Type of fracture | |||
| Femoral neck | 190(53.82) | 172(59.52) | 18(28.13) |
| Intertrochanteric | 145(41.08) | 101(34.95) | 44(68.75) |
| Subtrochanteric | 6(1.70) | 4(1.38) | 2(3.13) |
| Periprosthetic | 5(1.42) | 5(1.73) | 0(0) |
| Multiple hip fractures | 7(1.98) | 7(2.42) | 0(0) |
| Type of surgery | |||
| Intramedullary nail | 140(39.65) | 102(35.29) | 38(59.38) |
| Cancellous screw | 45(12.75) | 36(12.46) | 9(14.06) |
| Hemiarthroplasty | 121(34.28) | 116(40.14) | 5(7.81) |
| Total hip arthroplasty | 42(11.90) | 32(11.07) | 10(15.63) |
| Revision of arthroplasty | 5(1.42) | 3(1.04) | 2(3.13) |
| Surgical delay | |||
| <24 h | 22(6.23) | 22(7.61) | 0(0) |
| 24–72 h | 285(80.74) | 34(11.76) | 52(81.25) |
| >72 h | 46(13.03) | 233 (80.62) | 12(18.75) |
| Duration of surgery | 3.15 ± 0.93 | 3.08 ± 0.85 | 3.48 ± 0.81 |
| General anesthesia | 35(9.92) | 27(9.34) | 8(12.5) |
| High-risk medications in surgery | |||
| Benzodiazepines | 59(16.71) | 26(8.99) | 33(51.56) |
| Opioids | 233(66.01) 78(22.10) | 167(57.79) 63(21.80) | 12(18.75) |
| NSAIDs | 15(23.44) | ||
| Glucose level for patients with diabetes (mmol/L) | 8.69 ± 1.57 | 7.14 ± 3.44 | 8.85 ± 1.50 |
| Sodium | 134.02 ± 17.28 | 135.25 ± 18.72 | 136.39 ± 9.63 |
| BUN | 7.84(5.25–8.73) | 6.38(5.02–8.08) | 7.93(6.45–10.25) |
| Creatine | 58(54–89) | 67(55–85) | 69(59.05–99) |
| Albumin | 35.66 ± 4.42 | 35.95 ± 5.65 | 35.26 ± 4.92 |
| White blood cell count | 8.55 ± 2.97 | 7.98 ± 2.56 | 8.26 ± 3.77 |
| Hemoglobin | 119(99–127) | 122(104–133) | 105(88–104.8) |
Data are given as a number (%), mean + standard deviation, or median (interquartile range).
ADL, activities of daily living; BMI, body mass index; BUN, blood urea nitrogen; CCI, Carlson comorbidity index; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease; NSAIDs, nonsteroidal anti-inflammatory drugs.
Figure 3Comparison of the performance of the prediction model in the derivation and validation cohorts. AUC, area under the curve.
Figure 4Calibration plot for the prediction model in the derivation and validation cohorts.